"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 3 | 3 |
| 2003 | 2 | 2 | 4 |
| 2004 | 0 | 6 | 6 |
| 2005 | 1 | 3 | 4 |
| 2006 | 2 | 3 | 5 |
| 2007 | 2 | 3 | 5 |
| 2008 | 0 | 3 | 3 |
| 2009 | 1 | 6 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 1 | 4 | 5 |
| 2012 | 2 | 4 | 6 |
| 2013 | 4 | 5 | 9 |
| 2014 | 6 | 2 | 8 |
| 2015 | 4 | 4 | 8 |
| 2016 | 3 | 6 | 9 |
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 6 | 9 |
| 2019 | 8 | 4 | 12 |
| 2020 | 1 | 9 | 10 |
| 2021 | 3 | 5 | 8 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker. Europace. 2022 07 21; 24(7):1119-1126.
-
The evaluation of reporting of patient-reported outcomes in MDD: A meta-epidemiological study of clinical trials. J Psychiatr Res. 2022 06; 150:79-86.
-
Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype. Mol Genet Metab. 2021 11; 134(3):217-222.
-
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice. Eur J Cancer. 2021 11; 157:140-152.
-
Best Practices for Conducting Clinical Trials With Indigenous Children in the United States. Am J Public Health. 2021 09; 111(9):1645-1653.
-
Demographic diversity of participants in Pfizer sponsored clinical trials in the United States. Contemp Clin Trials. 2021 07; 106:106421.
-
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation. Gynecol Oncol. 2021 07; 162(1):203-209.
-
Considerations for treatment duration in responders to immune checkpoint inhibitors. J Immunother Cancer. 2021 03; 9(3).
-
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer. Cancer Chemother Pharmacol. 2021 05; 87(5):689-700.
-
Race in Rhinology Clinical Trials: A Decade of Disparity. Laryngoscope. 2021 08; 131(8):1722-1728.